Blog › posts about Drug Discovery
Posts about Drug Discovery
Everything you need to know about the FDA Modernization Act 2.0
6 March 2023 •
by Zara Puckrin, BSc
Everything you need to know about the motilin receptor
21 February 2023 •
by Zara Puckrin, BSc
Make a Difference with Fresh Residual Human Tissue Donation for Research – How to Get Involved!
31 January 2023 •
by Karen McAulay, PhD
From rat aorta to resistance arteries: measuring vascular contractility
16 January 2023 •
by Zara Puckrin, BSc
Everything we know about resistance arteries
21 November 2022 •
by Zara Puckrin, BSc
4 ways ex vivo models offer Pharma better alternatives to animal testing
1 November 2022 •
by Zara Puckrin, BSc
Everything we know about the human relaxin peptide family
28 September 2022 •
by Zara Puckrin, BSc
Endogenous and exogenous affectors of uterine contractility
27 September 2022 •
by Zara Puckrin, BSc
How human fresh tissue models are helping RCD405 achieve regulatory approval
17 August 2022 •
by Zara Puckrin, BSc
What are nonclinical cardiovascular safety pharmacology studies?
3 August 2022 •
by Zara Puckrin, BSc
Everything you need to know about the 5-HT2B receptor
1 July 2022 •
by Zara Puckrin, BSc
Limitations of the isolated perfused heart and alternative models
24 May 2022 •
by Zara Puckrin, BSc
Everything we know about the 5-HT2A (serotonin) receptor
4 May 2022 •
by Zara Puckrin, BSc
The influence of the microbiome on inflammatory bowel disease
18 March 2022 •
by Lindsey Moffitt, BSc
REPROCELL Solutions for Skin Disease Researchers
4 March 2022 •
by Karen McAulay, PhD
Predicting Psoriasis Drug Efficacy in Human Skin [INFOGRAPHIC]
3 March 2022 •
by Zara Puckrin, BSc
Inserts or plates for your 3D cell culture?
28 February 2022 •
by Frederique Tholozan, PhD
How to improve your 3D Cell Culture using Small-scale Perfusion Systems
15 February 2022 •
by Frederique Tholozan, PhD
Enhance your epithelial barriers assay using Alvetex
7 February 2022 •
by Frederique Tholozan, PhD
How to bioengineer epithelial tissues in vitro
25 May 2021 •
by Lydia Costello, PhD
Precision medicine for COVID-19 pandemic
3 February 2021 •
by Katerina Boididou, MSc
This light-activated treatment could help patients with peripheral artery disease [INTERVIEW]
1 September 2020 •
by Zara Puckrin, BSc
4 Examples of human models of respiratory diseases
3 August 2020 •
by Frederique Tholozan, PhD
Using 3D culture to improve Caco-2 permeability assays
14 July 2020 •
by Matthew Freer
How to Characterize the Barrier Properties of Alvetex®-Based Mucosal Models
6 April 2020 •
by Nicole Darling
4 reasons human tissues should be used to predict drug bioavailability
29 January 2020 •
by Zara Puckrin, BSc
How to estimate drug permeability using the Ussing Chamber technique
22 January 2020 •
by Zara Puckrin, BSc
IBDiscovery: Combining patient and drug discovery data to transform healthcare
16 September 2019 •
by Jennifer McCavitt
Advances in diagnostics, treatments, and frontiers of research in IBD
13 June 2019 •
by Chris Hissom, MBA
How Human Organoculture can be used to Improve Precision Medicine Strategies
5 June 2019 •
by Karen Cowan, MSc
Will The Microbiome Become The Next Hot Topic For Cancer Research?
16 May 2019 •
by Amna Rehman, BSc
REPROCELL Solutions for Respiratory Disease Researchers
29 April 2019 •
by Karen McAulay, PhD
The gut microbiome in health and disease: the future for diagnosis and treatment of IBD and IBS?
12 February 2019 •
by David Bunton, PhD
REPROCELL Solutions for Gastrointestinal Researchers
25 October 2018 •
by Karen McAulay, PhD
IBD drug discovery and human tissue research
7 September 2018 •
by Zara Puckrin, BSc
How animal testing is inaccurate and the alternatives
25 May 2018 •
by David Bunton, PhD
Human Tissue Testing in Drug Discovery and Development
27 March 2018 •
by Karen McAulay, PhD